Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 3, 2007, Pages 267.e1-267.e4

  Toso, Laura ^a   Johnson, Andrea ^a   Bissell, Stephanie ^a   Roberson, Robin ^a   Abebe, Daniel ^a   Spong, Catherine Y ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

activity dependent neuroprotective protein (ADNP); activity dependent neurotrophic factor (ADNF); gamma aminobutyric acid (GABA); learning; N methyl d aspartate (NMDA)

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PEPTIDE; PLACEBO; SERYLALANYLLEUCYLLEUCYLARGINYLSERYLISOLEUCYLPROLYLALANINE; SYNPEP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; FETUS DEVELOPMENT; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

EID: 34548449897     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.049     Document Type: Article

References (22)

1. Toso L., Endres M., Vink J., Abebe D.T., Brenneman D.E., and Spong C.Y. Learning enhancement with neuropeptides. Am J Obstet Gynecol 194 (2006) 1153-1159
2. Vink J., Auth J., Abebe D.T., Brenneman D.E., and Spong C.Y. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol 193 (2005) 825-829
3. Spong C., Wood L., Poggi S., et al. Postnatal therapy to prevent alcohol-induced learning abnormalities in fetal alcohol syndrome. Am J Obstet Gynecol 189 suppl (2003) S63
4. Zhou F.C., Sari Y., Powrozek T.A., and Spong C.Y. A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth. J Mol Neurosci 24 (2004) 189-199
5. Gozes I., Giladi E., Pinhasov A., Bardea A., and Brenneman D.E. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharm Exp Ther 293 (2000) 1091-1098
6. Gozes I., Bachar M., Bardea A., et al. Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease. J Neurobiol 33 (1997) 329-342
7. Brenneman D.E., Spong C.Y., Hauser J.M., et al. Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther 309 (2004) 1190-1197
8. Toso L., Cameroni I., Schmidt C., Abebe D., Bissell S., and Spong C.Y. Prevention of developmental delays in a down syndrome model. Am J Obstet Gynecol 195(suppl) (2006) S13
9. Toso L., Poggi S.H., Roberson R., et al. Prevention of alcohol-induced learning deficits in fetal alcohol syndrome mediated through NMDA and GABA receptors. Am J Obstet Gynecol 194 (2006) 681-686
10. Toso L., Roberson R., Abebe D., and Spong C.Y. Neuroprotective peptides prevent some alcohol-induced alteration in GABAβ3 which plays a role in cleft lip and palate and learning in fetal alcohol syndrome. Am J Obstet Gynecol 196 (2007) 259 e1-259.e5
11. Sucher N.J., Awobuluyi M., Choi Y.B., and Lipton S.A. NMDA receptors: from genes to channels. Trends Pharmacol Sci 17 (1996) 348-355
12. Freund T.F., and Buzsàki G. Interneurons of the hippocampus. Hippocampus 6 (1996) 347-470
13. Morris R.G.M. Long-term potentiation and memory. Phil Trans R Soc Lond 358 (2003) 643-647
14. Perez-Otano I., and Ehlers M.D. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 13 (2004) 175-189
15. Barker J.L., Behar T., Li Y.X., et al. GABAergic cells and signals in CNS development. Perspect Dev Neurobiol 5 (1998) 305-322
16. A receptors. Brain Res 29 (1999) 196-217
17. Zhang T.A., Hendricson A.W., Wilkemeyer M.F., Lippmann M.J., Charness M.E., and Morrisett R.A. Synergistic effects of the peptide fragment D-NAPVSIPQ on ethanol inhibition of synaptic plasticity and NMDA receptors in rat hippocampus. Neuroscience 134 (2005) 583-593
18. Boehm II S.L., Ponomarev I., Jennings A.W., et al. Gamma-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol 68 (2004) 1581-1602
19. Divinski I., Mittelman L., and Gozes I. A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem 27 (2004) 28531-28538
20. White D., Walker S., Brenneman D.E., and Gozes I. CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal peptide and activity-dependent neurotrophic factor. Brain Res 868 (2000) 31-38
21. Glazner G.W., Boland A., Dresse A.E., Brenneman D.E., Gozes I., and Mattson M.P. Activity-dependent neurotrophic factor peptide (ADNF9) protects neurone against oxidative stress-induced death. J Neurochem 73 (1999) 2341-2347
22. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E., and Hill J.M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 297 (2001) 774-779